Submit a notification by the deadline to keep active substances in the EU Review Programme
The European Chemicals Agency (ECHA) has published open invitations to provide an opportunity for a person, company or task force/consortium to notify an intention to take up or take over the role of participant in the EU Review Programme for the following active substance/product type combinations.
This affects NI. Anyone wishing to support one of the active substance/product type combinations listed below in the EU will need to submit a notification to ECHA by the following deadlines:
- 7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole (EDHO) (CAS 7747-35-5 EC 231-810-4) in product types 6 and 13
6 July 2022
- cis-1-(3-chloroallyl)-3,5,7-triaza-1- azoniaadamantane chloride (cis CTAC) (CAS 51229-78-8 EC 426-020-3) in product types 6 and 13
6 July 2022
- Methenamine 3-chloroallylochloride (CTAC) (CAS 4080-31-3 EC 223-805-0) in product types 6, 12 and 13
6 July 2022
If a notification to take over the role of participant is not received, these active substance/product type combinations will be subject to an EU non-approval decision.
Biocidal products containing active substances with EU non-approval decisions for the relevant product types will have to be removed from the NI market. HSE will provide separate updates on these where relevant.
If you are aware of any disproportionate negative effects that are likely to arise from the non-approval of any of the active substance/product type combinations listed above, please contact us.
Biocidal products must be phased off the NI market
The active substance/product type combination listed below is due to expire under the EU BPR on the following date. This affects NI:
- Carbon dioxide (CAS 124-38-9 EC 204-696-9) in product type 18
31 October 2022
Once the approval expires, the active substance can no longer be used in biocidal products of the relevant product type in NI.
If you hold an affected EU BPR product authorisation or Control of Pesticides Regulations (COPR) product approval, we will contact you about cancelling or revoking your authorisation or approval. You will have an opportunity to submit comments or additional information and we will take account of these when finalising our decision.
If you are aware of any disproportionate negative effects that are likely to arise from the expiry of any of the active substance/product type combinations listed above, please contact us.
Make sure you are receiving important information about your product authorisations and approvals
If you hold product authorisations and approvals in NI under the EU BPR or the COPR, you should make sure HSE has the right contact details for you.
If the details we hold are out of date, you may not receive important information about your product authorisation or approval.
Update your details.
|